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GLI2 induces genomic instability in human
keratinocytes by inhibiting apoptosis
E Pantazi1, E Gemenetzidis1, G Trigiante1, G Warnes2, L Shan3, X Mao3, M Ikram4, M-T Teh5, Y-J Lu3,6 and MP Philpott*,1,6
Abnormal Sonic Hedgehog signalling leads to increased transcriptional activation of its downstream effector, glioma 2 (GLI2),
which is implicated in the pathogenesis of a variety of human cancers. However, the mechanisms underlying the tumorigenic
role of GLI2 remain elusive. We demonstrate that overexpression of GLI2-b isoform, which lacks the N-terminal repressor domain
(GLI2DN) in human keratinocytes is sufficient to induce numerical and structural chromosomal aberrations, including
tetraploidy/aneuploidy and chromosomal translocations. This is coupled with suppression of cell cycle regulators p21WAF1/CIP1
and 14-3-3r, and strong induction of anti-apoptotic signalling, resulting in a reduction in the ability to eliminate genomically
abnormal cells. Overexpression of GLI2DN also rendered human keratinocytes resistant to UVB-mediated apoptosis, whereas
inhibition of B-cell lymphoma 2 (BCL-2) restored endogenous (genomic instability (GIN)) and exogenous (UVB) DNA damage-
induced apoptosis. Thus, we propose that ectopic expression of GLI2 profoundly affects the genomic integrity of human
epithelial cells and contributes to the survival of progenies with genomic alterations by deregulating cell cycle proteins and
disabling the apoptotic mechanisms responsible for their elimination. This study reveals a novel role for GLI2 in promoting GIN, a
hallmark of human tumors, and identifies potential mechanisms that may provide new opportunities for the design of novel forms
of cancer therapeutic strategies.
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Multiple genetic alterations are required for cancer develop-
ment, and understanding the mechanisms that promote and
enhance DNA damage is important. One of the hallmarks of
cancer is genomic instability (GIN) and this is reflected in the
heterogeneity seen within individual tumors and the extensive
genomic alterations in cancer cells, responsible for both
cancer development and treatment failure.1 GIN refers to a set
of events capable of causing unscheduled alterations either of
a temporary or permanent nature within the genome.2 GIN
can be divided into two major groups: (1) microsatellite
instability, occurring at the nucleotide level, due to faulty
DNA repair pathways and (2) chromosomal instability
(CIN), defined as an accelerated rate of chromosomal
alterations due to increased chromosome damage, defects
in end-joining repair mechanisms and errors in chromosome
segregation.2–4 Chromosome alterations, which commonly
occur in human cancers, can be classified as structural
alterations, including inversions, deletions, amplifications,
duplications and translocations, and numerical changes –
denoting gains or losses of whole chromosomes, leading to
aneuploidy.2,4,5 Genomic abnormalities tend to induce
apoptosis as a default pathway that aborts cells with damaged
DNA.4,6–8 In addition to the increased rate in generating genomic
alterations, inactivation of checkpoint and genomic surveillance
genes is critical during the development of GIN by allowing the
accumulation of gene mutations, chromosome damage and
ploidy abnormalities.2–4,7,8
Basal cell carcinoma (BCC) of the skin is the most common
malignancy in humans. Several studies have provided
evidence of GIN in BCCs, highlighting their multiclonal nature
and the presence of numerical chromosomal alterations,
gene amplification, multinucleated cells and chromosome
polysomy.9–15 The development of BCC is associated with
aberrant activation of the Hedgehog (HH) signalling pathway,
which leads to increased expression and activation of glioma
(GLI; GLI1 and GLI2) transcription factors, the principal
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effectors of the HH pathway.16 Targeted expression of an
activemutant of GLI2 (GLI2DN – a constitutively active form of
GLI2 isoform b, lacking the N-terminal repressor domain) is
sufficient to induce the formation of BCC-like lesions in the
epidermis of transgenic mice17–19 and is required for their
maintenance.20 Moreover, GLI2 is consistently upregulated
in tumors that display complex genomic alterations.21–30
However, the role of GLI2 in GIN remains elusive. Therefore,
we investigated whether GLI2 influences the genomic integrity
of epidermal keratinocytes. We found that ectopic expression
of GLI2DN profoundly affected the genomic stability of human
epidermal keratinocytes, partly by suppressing cell cycle
checkpoint proteins and disabling the intrinsic apoptotic
mechanisms responsible for the elimination of cells with
genomic alterations, thus identifying a novel role for GLI2 in
tumorigenesis.
Results
Generation and characterisation of EGFP-GLI2DN stable
expressing cells. Human telomerase-immortalised new-
born epidermal (N/TERT) keratinocytes stably expressing
enhanced green fluorescent protein (EGFP; SINCE) or
enhanced green fluorescent protein-GLI2-b isoform, which
lacks the N-terminal repressor domain (EGFP-GLI2DN;
SINEG2) were generated and expression of the fusion
product was confirmed by mRNA expression, fluorescent
microscopy, flow cytometry and western blot analysis
(Supplementary Figure S1). The effect of GLI2DN on
N/TERT cell proliferation was analysed by the Alamar
blue and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide) cell viability assays, revealing signifi-
cantly less SINEG2 cells compared with parental N/TERT or
N/TERT keratinocytes stably expressing EGFP (SINCE)
cells after 7 days in culture. Over prolonged culture (16
days), SINEG2 cells underwent fewer population doublings
than either of the control cells. Collectively, these data show
that ectopic GLI2DN reduces the proliferation rate of N/TERT
cells (Supplementary Figure S2).
GLI2 induces tetraploidy and numerical chromosomal
alterations. Cell cycle analysis after Hoescht-33342 staining
revealed a significant increase in the 4N population in
SINEG2 (Supplementary Figure S3), which could be caused
either by a G2/M block, or by an abnormal accumulation of
tetraploid/near-tetraploid cells. The latter was confirmed by
further analysis using propidium iodide, which showed that
SINEG2 cells have a significant increase in the percentage of
polyploid and aneuploid cells with 8N and 44N, compared
with N/TERT and SINCE cells (Figures 1a and b), indicating
that GLI2DN expression promotes polyploidy and aneu-
ploidy. Similarly, cell cycle analysis in primary normal human
epidermal keratinocytes (NHEKs) and in human uterus
endometrium leiomyosarcoma (SK-UT-1B) diploid cells,
overexpressing GLI2DN, showed a significant increase in the
percentage of 4N and 44N cells (Supplementary Figure S4).
We also found enlarged, bi- and multinucleated SINEG2 cells
by in situ Hoechst-33342 staining (Figure 1c), indicating the
existence of binucleated tetraploid/near-tetraploid and
multinucleated polyploid and aneuploid cells, caused by
cytokinesis failure.
Furthermore, we counted the proportion of binucleated
N/TERT,SINCEandSINEG2 cells stainedwithDAPI and found
a significantly (Po0.01) elevated percentage of binucleated
cells (B19%) in SINEG2 compared with both control cell lines
(5.4% for N/TERT and 4.2% for SINCE; Figure 1d).
The difference in binucleated cells (B14%) is consistent with
the differences in 4N populations measured by flow cytometry
(B11–15%) between control (N/TERT and SINCE) and
SINEG2 keratinocytes (Supplementary Figure S3 and
Figure 1a), suggesting that the accumulation of 4N SINEG2
cells, observed by flow cytometry, is mainly due to the
presence of tetraploid/near-tetraploid cells rather than the
activation of the G2/M checkpoint of diploid cells. This is
further supported by the 8N and 44N DNA content cells
(Figures 1a and c). However, a transient arrest of cells, due to
activation of the mitotic spindle checkpoint, cannot be excluded
completely.
GLI2 induces structural chromosomal abnormalities.
We also revealed structural chromosomal abnormalities in
GLI2DN-expressing keratinocytes. Multiplex fluorescent
in situ hybridisation (M-FISH) analysis revealed a stable
karyotype of 47,XY,þ 20, therefore with the presence of an
extra chromosome 20 (trisomy 20) in the near-diploid male,
accounting for B90% of metaphases analysed from kerati-
nocyte cell lines N/TERT and SINCE (Figure 2a). The rest
were tetraploid cells with double number of each chromo-
some in the near-diploid cells. Trisomy 20 was further
confirmed by 10K SNP (single nucleotide polymorphism)
array analyses (GEO accession number: GSE36105), using
normal donor human skin keratinocytes as reference cells
(Supplementary Figure S5). No structural chromosome
aberrations were detected in the control N/TERT and SINCE
cells (Figure 2).
However, SINEG2 keratinocytes showed both numerical
and structural chromosome aberrations (Figure 2). Approxi-
mately 14% of metaphase SINEG2 cells were tetraploid
(94 chromosomes with the karyotype 94, XXYY, þ 20 2;
Figure 2b) andB70% were near-tetraploid/aneuploid cells
with random gains and losses of chromosomes (i.e., 73
chromosomes; Figure 2c), in contrast to control cells of which
onlyB10% were tetraploid. Interestingly, we found structural
chromosomal rearrangements in B29% (4/14) karyotyped
metaphases of SINEG2 keratinocytes, including a clonal
non-reciprocal chromosome translocation; t(7;14) in 3 of
14 karyotyped metaphases (Figures 2d and e), 1 is diploid
(Figure 2d) and the other 2 are near-tetraploid/aneuploid cells
(Figure 2e). A non-clonal unbalanced translocation t(9;14)
was also detected in a near-tetraploid/aneuploid SINEG2
keratinocyte (data not shown).
GLI2DN induction leads to impaired checkpoint
control and apoptosis for the survival of cells with
chromosomal abnormalities. Cells with numerical or
structural chromosome changes usually stimulate cell cycle
p53/p21WAF1/CIP1-dependent checkpoint arrest and/or
subsequent apoptosis.4,7,8,27,31–36 To understand how
such populations are maintained, we investigated whether,
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along with the generation of cells with accumulated genomic
alterations, GLI2DN also prevents the induction of the
‘tetraploidy checkpoint’ and apoptosis.
Although we detected a marginal increase of p53 protein
levels in SINEG2 keratinocytes (Figure 3a), its direct
transcriptional target p21WAF1/CIP1 was significantly down-
regulated (Figure 3b), indicating a defective G1 ‘tetraploidy
checkpoint’ in GLI2DN-expressing cells. This demonstrates
the ability of GLI2DN to suppress p21WAF1/CIP1 in a
p53-independent manner. p21WAF1/CIP1 was also found to
a b
c
d
Figure 1 GLI2DN induces tetraploidy, polyploidy and aneuploidy in N/TERT keratinocytes. (a) Propidium iodide staining, followed by flow cytometry analysis to obtain cell
cycle distribution of N/TERT (i), SINCE (ii) and SINEG2 (iii) cells. Sub-G1 trace was negligible for all cell lines examined. Data are representative of three independent
experiments. (b) Graphical representation of the percentage of (i) 8N and (ii)44N cells for each cell line after Hoechst-33342 staining and flow cytometry analysis. SINEG2
cells have significantly higher (Pr0.01) percentage of polyploid and aneuploid cells in culture. Each bar represents the mean values±S.E.M. of duplicate samples.
(c) Representative pictures taken from Hoechst-33342-stained SINEG2 cell line at  20 magnification, showing the presence of bi- and multinucleated cells. Black arrows
indicate binucleated cells and red arrows indicate multinucleated cells. DNA was detected by Hoechst-33342 staining (blue). (d) N/TERT, SINCE and SINEG2 cells were
stained with DAPI to visualise nuclear DNA. SINEG2 cells display a significant increase (B3.5 fold) in the population of binucleated (tetraploid/near-tetraploid) cells. Each bar
represents the mean values of binucleated cells per field±S.E.M. of 7 fields for N/TERT and SINCE, and 13 fields for SINEG2. Total count B300 cells per cell line.
**Pr0.01. N, haploid number
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be suppressed in humanBCCs, which areGLI2-driven tumors
sharing many attributes with the GLI2DN-expressing kerati-
nocytes (Supplementary Figure S6). 14-3-3s, another direct
transcriptional target of p53 after DNA damage and lost in
BCCs,37 was also downregulated in SINEG2 compared with
both N/TERT and SINCE keratinocytes (Figure 3c).
Following Annexin V staining, flow cytometry analysis
showed that upon expression of GLI2DN, despite the
presence of GIN, there was no difference in numbers of live,
early apoptotic, late apoptotic/dead cells, between control and
SINEG2 cells (Figure 3d), indicating lack of apoptosis induced
by genomic changes in GLI2DN-expressing cells.
B-cell lymphoma 2 (BCL-2) is a direct target of GLI2DN in
HaCaT keratinocytes and is highly expressed in human
BCCs.38 We found that the level of BCL-2 mRNA was
elevated by 11-fold in SINEG2 compared with N/TERT and
SINCE controls (Pr0.01; Figure 3e), whereas Bcl-2 protein
(Figure 3f) was massively upregulated in SINEG2 cells,
suggesting a role in preventing apoptosis in SINEG2 cells.
As GLI2DN-expressing cells are resistant to tetraploidy-
mediated apoptosis, we investigated whether GLI2
overexpression can also render cells resistant to other
apoptotic stimuli such as UV light, which is known to cause
p53-mediated induction of p21WAF1/CIP1 and apoptosis. UVB
irradiation is an established risk and aetiological factor in
human BCC formation. Following UVB irradiation, p53 was
upregulated in both GLI2DN-expressing and control keratino-
cytes (Figure 4a). However, p21WAF1/CIP1 was upregulated
only in control cells (Figure 4a) but remained suppressed in
SINEG2 cells (Figure 4a), further confirming that GLI2
suppresses p21 expression independently of p53. The
apoptotic response of N/TERT, SINCE and SINEG2 cells
Figure 2 GLI2DN induces numerical and structural chromosomal changes in human keratinocytes. (a) Representative metaphase cell from SINCE as a
DAPI-counterstained image (upper left), with the 24-colour-painted chromosomes (lower left) and a karyotype of 47, XY, þ 20, based on the colour code (right).
(b) Representative tetraploid metaphase cell from SINEG2 as a DAPI-counterstained image (upper left), with the 24-colour-painted chromosomes (lower left) and a karyotype
of 94, XXYY, þ 20 2 based on the colour code (right). (c) Metaphase aneuploid (near-tetraploid aneuploid) SINEG2 cell as a DAPI-counterstained image (upper left), with
the 24-colour-painted chromosomes (lower left) and a karyotype of 73, XXYY,  1,  2,  3 2,  4,  5,  6,  8,  9,  11 2,  12,  16 3,  17 2,  18
and  22, based on the colour code (right). This is an example of a tetraploid cell that might have undergone multipolar and asymmetric divisions, yielding aneuploid
progenies. (d) Diploid SINEG2 metaphase cell with the clonal nonreciprocal unbalanced translocation t(7;14; white arrows) as a DAPI-counterstained image (upper left), with
the 24-colour-painted chromosomes (lower left) and a karyotype of 47, XY,  7, þ del7q,  14, þ der(14)t(7;14), þ 20, based on the colour code (right). (e) Representative
near-tetraploid SINEG2 metaphase cell with the clonal nonreciprocal unbalanced translocation t(7;14; white arrows; upper left), with the 24-colour-painted chromosomes
(lower left) and a karyotype of 92, XXYY,  7 2, þ del7q,  14 2, þ der(14)t(7;14)X2,  18, þ 20 2, based on the colour code (right)
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following UVB irradiation (10 or 30mJ/cm2) was measured
against mock-irradiated controls (0mJ/cm2). SINEG2 display
a reduction of early apoptotic and late apoptotic/dead cells in
response to high (30mJ/cm2) dose of UVB irradiation (B9%
early apoptotic cells), compared with both N/TERT (B24%
early apoptotic cells) and SINCE (B24% early apoptotic cells)
control keratinocytes (Figure 4b). Similar results were
obtained with a lower (10mJ/cm2) UVB dose (Po0.001;
Figure 4c). Furthermore, the absence of activated/cleaved
Caspase-3 (Figure 4d), in combination with the high-level of
Bcl-2 (Figure 4d), further confirm that SINEG2 keratinocytes
are able to escape p53-mediated apoptosis.
Inhibition of BCL-2 restores endogenous (chromosomal
alterations) and exogenous (UVB) DNA-damage-induced
apoptosis to GLI2DN-expressing keratinocytes. Activation
of the anti-apoptotic signalling is essential for the survival of
cells with endogenous (i.e., GIN) or exogenous (i.e., UVB)
DNA damage, and is one of the mechanisms employed by
cancer cells to evade apoptosis. Our results suggest a pivotal
role for BCL-2 in the survival of cells overexpressing GLI2DN.
We inhibited BCL-2 in N/TERT, SINCE and SINEG2
keratinocytes using a range of concentrations of Navitoclax
(ABT-263), and measured apoptosis by Annexin V staining
and cleavage of Caspase-3. Navitoclax is a potent inhibitor of
the Bcl-2/Bcl-xL proteins, which restores the intrinsic pathway
activity in response to apoptotic stimuli.39,40 By Annexin V flow
cytometry analysis, we show that SINEG2 cells become highly
sensitised to low and high doses of Navitoclax (Figure 5a and
Supplementary Figure S7A), which correlates with the
increased cleavage of Caspase-3 protein (Figure 5b (iii) and
Supplementary Figure S7B), which occurred even at
the low dose of 0.1mM of Navitoclax (Figure 5b (iii)).
In contrast, normal N/TERT and SINCE control cells required
at least a minimum dose of 5mM before Caspase-3 protein
cleavage becomes detectable (Figure 5b (i and ii) and
Supplementary Figure S7B), suggesting lower apoptotic
induction of normal human keratinocytes to BCL-2 inhibition
compared with GLI2DN-expressing keratinocytes.
To determine whether the resistance of GLI2DN-expres-
sing cells to UVB-induced apoptosis can be attributed to the
elevated levels of BCL-2, we investigated the effects of
Navitoclax on apoptosis of SINEG2 cells in response to UVB
(30mJ/cm2). Much lower doses of Navitoclax (ABT-263;
0.001–0.25 mM) were used due to possible synergistic effects
with UVB. Annexin V staining (Figure 5c (i)) and immunoblotting
analysis (Figure 5d and Supplementary Figure S7C) showed
that SINEG2 cells retain their resistance to UVB-induced
apoptosis, during treatment with very low doses of Navitoclax
(0.001–0.01 mM), compared with N/TERT and SINCE control
cells. These doses of the drug may be insufficient to fully
inhibit the function of BCL-2, especially in SINEG2 cells where
the basal levels of BCL-2 protein are dramatically elevated.
Consistently, at higher doses of Navitoclax (40.01 mM), the
number of apoptotic SINEG2 cells rises sharply and
surpasses that of N/TERT and SINCE cells (0.05–0.25 mM;
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Figure 5c), again indicating increased induction of apoptotic
cell death in SINEG2 cells. Immunoblotting analysis
showed that the cleavage of Caspase-3 at doses 40.01 mM
(i.e., 0.05mM)was higher in SINEG2 than in N/TERT and SINCE
control cells (Figure 5d and Supplementary Figure S7C).
Our results indicate that the survival of GLI2DN-expressing
cells largely depends on BCL-2. Once its function is
pharmacologically inhibited, cells become hyper-sensitised
to apoptotic cell death. As tetraploidy/aneuploidy itself is a
strong apoptotic signal, blocking the function of BCL-2 is
expected to induce a marked apoptotic response and the
reduction of abnormal tetraploid/aneuploid progenies. We
tested this hypothesis by treating SINEG2 cells with a range of
doses of BCL-2 inhibitor Navitoclax (ABT-263) before
examining their DNA content profile. As expected, treatment
over a range of concentrations of Navitoclax induced much
higher levels of apoptosis in SINEG2 cells, detectable by DNA
fragmentation (sub-G1; Figures 6a and b (i)), compared with
normal control N/TERT and SINCE cells (Supplementary
Figure S7D). The numbers of cells with DNA content 4N
(G2/M normal diploid cells and tetraploid/near-tetraploid G1
cells), as well as those with DNA content44N (polyploid and
aneuploid cells), also decreasedwith increasing concentrations
of Navitoclax. By quantifying the numbers of cells in each
group, we observed that cells with DNA content of 4N and
those with DNA content44N were most significantly affected
by treatment with Navitoclax (Figure 6b).
The fact that N/TERT and SINCE cells are not equally
sensitised to BCL-2 inhibition compared with SINEG2 cells
suggests that the tetraploid and near-tetraploid G1 SINEG2
cells (4N) may be more sensitive to BCL-2 inhibition than the
diploid G2/M cells (also 4N), due to apoptosis induced by
genomic changes. Interestingly, the number of S-phase cells is
also gradually elevated with increasing doses of the drug in
SINEG2 cells (Figure 6b) compared with that in N/TERT
and SINCE normal diploid control cells (Supplementary Figure
S7D). This population represents cells with a possible S-phase
arrest and/or 4N cells with fragmented DNA due to apoptosis.
As the normal control N/TERTandSINCE cells do not showany
evidence of S-phase arrest (Supplementary Figure S7D), the
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increased number of SINEG2 cells in S phase may consist
mainly of apoptotic tetraploid and near-tetraploid G1 cells (4N).
The number of cells with DNA content 2N (G1) appears to be
stable across treatment with different doses of Navitoclax
and only shows a significant decrease at 20 and 30 mM
of Navitoclax (Figure 6b). However, this reduction in cell
number is less than that seen for cells withDNA content 4Nand
44N. Collectively, we showed that inhibition of BCL-2
function by Navitoclax affects the survival of genomically
unstable tetraploid/aneuploid SINEG2 cells more than stable
diploid cells.
Discussion
GLI2 is frequently overexpressed in human cancers asso-
ciated with aneuploidy and CIN, including human BCCs,
prostate, breast, hepatocellular, colon and oral squamous
cancers, osteosarcomas and melanomas.5,10,12,21–30,38,41–44
However, its role in aneuploidy and CIN has not previously
been reported. In this study we showed that stable over-
expression of the constitutively active form of GLI2 in N/TERT
human epidermal keratinocytes resulted in the accumulation
and increased viability of cells with both numerical
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Figure 5 BCL-2 inhibition leads to apoptosis sensitisation of GLI2DN-expressing cells and abolishes their resistance to UVB-mediated apoptosis. (a) N/TERT, SINCE and
SINEG2 cells were either untreated (0 mM/DMSO) or treated with increasing concentrations of Navitoclax (ABT-263; 0.025–100mM) and were incubated for 24 h. Next,
apoptosis was detected by Cy5 Annexin V and DAPI staining, followed by flow cytometry analysis showing that SINEG2 cells have much higher apoptotic sensitivity to BCL-2
inhibition compared with control cells. Each point represents the mean fold change in the number of early (Annexin V (þ ) DAPI ( )) and late (Annexin V (þ ) DAPI (þ ))
apoptotic cells relative to the treatment with vehicle-only (0mM/DMSO) control for each individual cell line (arbitary value 1)±S.E.M. of duplicate samples. *Pr0.05,
**Pr0.01, ***Pr0.001. (b(i)) N/TERT, (ii) SINCE and (iii) SINEG2 cells were either untreated (0mM/DMSO) or treated with increasing doses of Navitoclax (ABT-263; 0.025–
30mM) and were incubated for 24 h. Next, cells were collected and whole-cell lysates were prepared and immunoblotted against anti-full-length Caspase 3 (B35 kDa)
antibody, whereas b-actin (B42 kDa) was used as a protein-loading control. Apoptosis was assessed through detecting the cleaved bands of Caspase-3 (B19, 17 kDa). In c
and d, N/TERT, SINCE and SINEG2 cells were either untreated (0 mM/DMSO) or treated with different concentrations of Navitoclax (ABT-263; 0.001–0.25 mM) for up to 24 h.
Cells were irradiated with a single dose of 30mJ/cm2 and were allowed to grow for anotherB20 h. Next, apoptosis was detected either by (c) Cy5 Annexin V and DAPI
staining, followed by flow cytometry analysis or by (d) immunoblotting analysis, showing that inhibition of BCL-2 abolishes the resistance of GLI2DN-expressing cells to UVB-
induced apoptosis. (c(i)) Each point represents the mean values/percentages of early (Annexin V (þ ) DAPI ( )) and late (Annexin V (þ ) DAPI (þ )) apoptotic
cells±S.E.M. of three independent experiments. *Pr0.05, **Pr0.01; (ii) each point represents the mean fold change in the number of early (Annexin V (þ ) DAPI ( )) and
late (Annexin V (þ ) DAPI (þ )) apoptotic cells relative to the treatment with vehicle-only (0mM/DMSO) and 30mJ/cm2 UVB control for each individual cell line (arbitary value 1)
±S.E.M. of three independent experiments. *Pr0.05, **Pr0.01, ***Pr0.001. (d) Whole-cell lysates were prepared and immunoblotted against anti-full-length Caspase 3
(B35 kDa) antibody, whereas b-actin (B42 kDa) was used as a protein-loading control
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and structural chromosomal alterations, revealing potential
novel mechanisms by which GLI2 might exert its tumorigenic
effect.
Cell cycle analysis of N/TERT keratinocytes expressing
GLI2DN showed that cells displayed an increased percentage
of 4N cells, including many binucleated tetraploid cells of G1
biochemical state, as well as an increased proportion of
polyploid and aneuploid cells with DNA content 8N and44N
representing G2/M- and S-phase tetraploid/near-tetraploid
aneuploid cells. These findings indicate that overexpression
of GLI2DN can interfere with normal cell cycle completion.
This effect is not cell line specific, as we observed similar
effects when GLI2DN was overexpressed in NHEK and in the
diploid tumorigenic line SK-UT-1B. Moreover, the increase in
tetraploid cells observed on GLI2DN induction may be a
contributing factor in cell transformation and carcinogenesis,
by promoting GIN/CIN and the formation of aneuploid cells.6,33
Tetraploidy is commonly seen in human cancer, including
GLI2DN-driven malignancies, such as BCCs,5,6,27,45–47 and
has been reported as an early step in human tumorigenesis
and a contributing factor in the generation of aneuploid
tumors.4,6,7,27,33,48–50 Tetraploidy also has its own tumori-
genic potential, as only tetraploid, and not diploid, p53-null
mouse mammary epithelial cells promote tumorigenesis after
subcutaneous injection into nude mice.48
In addition to numerical chromosomal aberrations, GLI2DN-
overexpressing keratinocytes presented with structural
chromosomal abnormalities, such as translocations. The
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Figure 6 BCL-2 inhibition leads to the induction of apoptosis and reduction of abnormal tetraploid and aneuploid cells in SINEG2 cultures. SINEG2 cells were either
untreated (0mM/DMSO) or treated with increasing concentrations of Navitoclax (ABT-263; 0.1–30mM) and were incubated for 24 h. Next, cells were stained with propidium
iodide (PI) followed by flow cytometry analysis to obtain cell cycle distribution of SINEG2 cells. (a) DNA content profiles of SINEG2 cells after treatment with various doses of
Navitoclax (ABT-263) (i–vi). Data are representative of three independent experiments, each of which consisted of duplicate samples. N, haploid number. (b) Graphical
representations of flow cytometry analysis; (i) each bar represents the mean values/percentages of SINEG2 cells±S.E.M. of duplicate samples present in each different
phase of the cell cycle (apoptotic sub-G1, G1, S, G2/M, DNA content44N). *Pr0.05, **Pr0.01, ***Pr0.001. Black arrow represents the increasing doses of Navitoclax
(ABT-263; 0/DMSO, 0.1, 0.5, 1, 5, 10, 15, 20, 30 mM); (ii) each bar represents the mean fold change in the number of treated SINEG2 cells relative to the treatment with
vehicle-only (0 mM/DMSO) control for each different phase of the cell cycle (G1, S, G2/M, DNA content44N; arbitary value 1)±S.E.M. of duplicate samples. *Pr0.05,
**Pr0.01, ***Pr0.001
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identification of the clonal translocation t(7;14) both in
near-tetraploid/aneuploid and diploid SINEG2 keratinocytes
on GLI2DN induction suggests that this chromosome
translocation event occurs in the diploid cell and
thus the ability of GLI2DN to induce structural chromo-
somal aberrations is independent of the induction of
tetraploidisation.
Here we propose two potential mechanisms by which
GLI2DN is able to induce tetraploidisation. First, by indirectly
downregulating 14-3-3s, whose loss leads to the improper
mitotic cap-independent translation of important executioners
of mitosis, cytokinesis failure and accumulation of binucleate
tetraploid cells,51 and is frequently seen in many cancers,
including breast, prostate and BCCs.37,52 Second, the down-
regulation of p21WAF1/CIP1 upon GLI2DN induction in vitro,
whichwas confirmed in humanBCCs in vivo, might be another
mechanism to promote tetraploidisation. As p21WAF1/CIP1
affects centrosome homeostasis, and its deficiency triggers a
bona fide overduplication of centrioles and thus aberrant
centrosome numbers,53 loss of p21WAF1/CIP1 may induce
centrosome overduplication-associated cytokinesis failure,54
resulting in increased binucleated tetraploidy and genomic
doubling.
Importantly, a low but detectable population of cells with 8N
DNA content was present in N/TERT and SINCE control cells.
This suggests the presence of spontaneously arising tetra-
ploid cells within the normal population. This is consistent with
a report showing that human N/TERT keratinocytes have low
rates of chromosomal non-disjunction during normal bipolar
mitoses, which leads to the generation of binucleated
tetraploid progenies (B2%) due to cytokinesis failure, instead
of aneuploid progenies.6,46 However, the majority of N/TERT
binucleated tetraploids did not proceed to the next division,46
possibly due to the activation of p53/p21WAF1/CIP1-dependent
checkpoint followed by apoptosis, previously shown to be
responsible for the restricted growth potential of tetraploid
cells.4,7,8,27,31–36 Consistently, a recent study55 showed that
elevating chromosome missegregation rates alone in human
cultured cells is not sufficient to convert stable, near-diploid
cells into highly aneuploid cells with karyotypes resembling
tumor cells. Thus, activation of oncogenes and/or loss
of tumor suppressor genes might be necessary at a
subsequent step, enabling binucleated tetraploid cells
to survive, proliferate and potentially give rise to aneuploid
cells. Taking into account the pivotal role of p21WAF1/CIP1
and 14-3-3s in the maintenance of genomic integrity of
cells2,3,8,56 and the prevention of tetraploidisation and
polyploidisation,4,7,51,53,57–59 the loss of both in GLI2DN-
expressing keratinocytes suggests a possible contribution not
only in the production of binucleated tetraploid cells but also in
the progression of cells with structural/numerical chromoso-
mal abnormalities through G1/S and G2/M cell cycle phases,
yielding polyploid and aneuploid progenies.
However, similar to the suppression of cell cycle regulators,
the inhibition of tetraploidy-induced apoptosis by GLI2
overexpression may be critical in the generation of GIN. It is
known that overexpressed BCL-2 inhibits apoptosis after a
failed cell division, resulting in enhanced survival of tetraploid
cells, which frequently undergo multipolar and asymmetric
divisions, leading to aneuploidy and extensive chromosomal
alterations.4,7,31,60 We found that GLI2DN induced BCL-2
overexpression, and by pharmacological inhibition of BCL-2
we confirmed that in GLI2DN-expressing keratinocytes, the
anti-apoptotic function of BCL-2 is more important to those
tetraploid/aneuploid cells than the genomically unchanged
cells. This not only showed that loss of BCL-2 function can
restore the apoptotic mechanism in GLI2DN-expressing cells
but also that genomically unstable cells rely muchmore on the
apoptosis-prevention role of BCL-2 than genomically stable
cells. In addition, by inhibiting the function of BCL-2 protein by
Navitoclax we showed that increased basal levels of BCL-2
are responsible for the resistance of GLI2DN keratinocytes to
UVB-mediated apoptosis. This is consistent with the apoptotic
resistance, mediated by intrinsic or extrinsic pathways, in
human BCCs.38,61,62 Overall, GLI2DN-expressing keratino-
cytes are resistant to both chromosomal alteration-mediated
and UVB/DNA-damage-induced apoptosis, and this may
explain how cells with genomic aberrations are able to escape
apoptosis and give rise to CIN.
The oncogenic activity of GLI2 interacts with a number of
biological processes, leading to the inhibition of apoptosis,
resistance to growth arrest and suppression of epithelial
differentiation; as such, Gli2DN alone is sufficient for the
generation of BCC tumors.17–19 In this study we show for the
first time, to our knowledge, that activation of GLI2DN can
induce GIN, a widespread feature of human cancer. There are
two mechanisms that cause GIN: (a) the increased genomic
alteration rate and (b) the loss of the surveillance of cells with
genomic defects, leading to the accumulation of cells with
genomic abnormalities. Our data suggest that GLI2 interferes
with both processes to contribute to GIN. By suppressing the
expression of both p21WAF1/CIP1 and 14-3-3s, GLI2 stimulates
CIN by increasing the rate of bi-/multinucleated cell genera-
tion. This, along with GLI2-stimulated BCL-2 overexpression,
suppress checkpoint and apoptosis activation in response to
endogenous (numerical and structural chromosomal altera-
tions) and exogenous (UVB) DNA damage. Together, GLI2
promotes CIN and the accumulation of chromosomal
abnormalities, which drive tumor formation. Although GIN is
a hallmark of human cancer, we provide evidence, indicating
that GLI2 may have a key role in driving such events in human
neoplasms.
Material and Methods
Plasmids and cloning. The self-inactivating retroviral vector (pSIN)-MCS
vector, containing an MCS insert, was cloned from pSIN-CMV-EGFP plasmid.63
The pSIN-CMV-GLI2DN-stable expression retroviral transduction vector was
obtained by excising the CMV-EGFP-GLI2DN ORF from pCMV-EGFP-GLI2DN
with SalI and MfeI and subcloning it into the pSIN-MCS vector cut with XhoI and
EcoRI.
Cell lines and culture. Human telomerase reverse-transcriptase (h/TERT)-
immortalised N/TERT-1 are derived from clinically normal foreskin tissue and were
supplied by Professor James Rheinwald (Department of Dermatology, Harvard
University Medical School, Boston, MA, USA). The telomerase-immortalised cell
line, N/TERT-1 (N/TERT)64 was chosen to examine GLI2DN effects because of its
genotype, which is comparable to primary human keratinocytes.64 This line retains
a functional p53/p21WAF1/CIP1 pathway, and although it has a potentially unlimited
lifespan because of abrogated senescence, it is neither tumour derived nor
malignant.64 N/TERT keratinocytes were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) high glucose, supplemented with 25% (v/v) Ham’s F12 medium
(PAA, Somerset, UK), 10% (v/v) fetal calf serum (FCS; Biosera, East Sussex, UK),
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1% (v/v) Glutamine (PAA), 1% (v/v) penicillin/streptomycin (PAA) and various
mitogens (0.4mg/ml hydrocortisone (Sigma-Aldrich, Dorset, UK), 0.1 nM cholera
toxin (BioMol, Exeter, UK), 5 mg/ml transferrin (Sigma-Aldrich), 20 pM liothyronine
(Sigma-Aldrich), 5 mg/ml insulin (Sigma-Aldrich) and 10 ng/ml epidermal growth
factor (AbD Serotec, Kidlington, UK)). Pimary NHEKs were cultured in a low CaCl2
(0.1mM; Gibco, Paisley, UK) keratinocyte serum-free medium (K-SFM; Life
Technologies, Paisley, UK), supplemented with 0.3 mM CaCl2 (Sigma-Aldrich),
25mg/ml bovine pituitary extract (Life Technologies), 0.2 ng/ml human epidermal
growth factor (Life Technologies) and 1% (v/v) penicillin/streptomycin (PAA).
Diploid SK-UT-1B cells were cultured in DMEM (PAA) high glucose, supplemented
with 10% (v/v) FCS, 1% (v/v) penicillin/streptomycin and 1% (v/v) glutamine.
Phoenix (human embryonic epithelial 293T derived) cells supplied by Nolan Lab
(Medical Center, Stanford University Medical School, Stanford, CA, USA), were
cultured in DMEM supplemented with 10% (v/v) FCS, 1% (v/v) penicillin/
streptomycin and 1% (v/v) glutamine. All cells were grown at 37 1C in a humidified
atmosphere of either 5% (v/v) CO2/95% (v/v) air (for NHEK and SK-UT-1B) or 10%
(v/v) CO2/90% (v/v) air (for N/TERT).
Retroviral infection. All transductions using pSIN-based constructs involved
transfecting the plasmid into the Phoenix packaging cell line using Fugene 6
Transfection Reagent (Roche Diagnostics, Burgess Hill, UK), according to the
manufacturer’s instructions, followed by selection of the cells with 3mg/ml
puromycin (Sigma-Aldrich) for 7–10 days. Next, cells were incubated in normal
growth medium at 32 1C overnight. The supernatant from virus-containing Phoenix
cells was collected once daily, one to two times post confluence. To infect N/TERT
keratinocytes, NHEK and SK-UT-1B cells were pre-incubated for 10min at 37 1C
in normal growth medium containing 5 mg/ml polybrene (Sigma-Aldrich), before
replacing with retroviral supernatant containing the same concentration of
polybrene (Sigma-Aldrich). Cells were centrifuged (350 g) at 32 1C for 1 h before
retroviral supernatant was replaced with normal growth medium and were kept in
normal culture condition. Transduced cells were incubated for at least 24 h before
being used for experiments. Because of lack of selectable markers, transduced
cells were fluorescent-activated cell sorted and collected in order to enhance the
percentage of cells that have the retroviral construct.
Fluorescent-activated cell sorting. All fluorescent activated cell sorting
(FACS) runs (sorting based on enhanced green fluorescence protein – EGFP
levels) were performed in a BD FACSAria Cell Sorter fitted with a Blue Argon
Laser 488 nm, violet diode 405 nm and red diode 633 nm (BD Biosciences,
San Jose, CA, USA). After washing with 1 PBS, cell pellets were resuspended
in 1 PBS each and then filtered through a 70-mm strainer. N/TERT and NHEK
and SK-UT-1B wild-type cells were used for obtaining basal levels of green
fluorescence (background autofluorescence), and all cells above this basal
threshold were considered as being EGFP-positive fluorescent cells, and were
thus sorted and plated in normal growth medium.
Light and fluorescence microscopy. Normal cultured cells, cultured
cells expressing EGFP or EGFP-GLI2DN fusion protein were visualised using a
light fluorescence microscope (Leica DM IRB/Nicon Eclipse TE-2000-S, Leica
Microsystems, Milton Keynes, UK) to detect cell morphology and gene/protein
expression. Images were captured with a digital imaging system (Leica DC2000
camera) attached to the microscope.
CAsy cell counter. Cell number and density of viable cells were determined
using CAsy Cell Counter (Innovatis, Sittingbourne, UK). Each sample (cell
suspension) was prepared three times in CAsyTon (Innovatis) buffer, followed by
triplicate measurements of 200ml sample volume. Viable cells were measured by
Casy Cell Counter, by excluding all counts that were of a size smaller that 10 mm
(dead cells and debris).
Proliferation assays. For MTT proliferation assay, cells were seeded in
separate (one for each time point) 24-well plates. The next day, cells were
incubated for 2 h in MTT (Sigma-Aldrich) and solution was prepared (growth
medium containing 10% (v/v) of MTT stock solution 5mg/ml) at 37 1C in a
humidified atmosphere of 10% (v/v) CO2/90% (v/v) air (Day 0). MTT formazan
crystals were solubilised in isopropanol (Fisher, Leicestershire, UK) and 100 ml of
the solution from each well was transferred to a well of a clear, flat-bottomed 96-
well plate (Nunc, Roskilde, Denmark). The absorbance (optical density) was
measured at 560 nm, using a 96-well microplate reader (FLUOSTAR OPTIMA
microplate reader, BMG LABTECH, Aylesbury, UK). For Alamar Blue assay, cells
were incubated in 10% Alamar Blue (Invitrogen, Paisley, UK) solution in growth
medium for 6 h at 37 1C in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air
(Day 0). Following incubation, 100ml of the target cell medium was obtained and
added in each well of an opaque, flat-bottomed 96-well microtiter white plate (Nunc).
Alamar Blue (Invitrogen) reduction (fluorescence) was read on a FLUOSTAR
OPTIMA microplate reader (BMG LABTECH) at 544 excitation wavelength and at
590 nm emission wavelength. Next, medium containing the Alamar Blue
(Invitrogen) was aspirated and cells were re-fed with fresh normal growth
medium. Samples were analysed in six replicates.
Population doublings. Keratinocyte population doublings were calculated
as follows: PD¼ 3.32 (log10 (N1) log10 (N0)), where N1¼ total yield (total
output) and N0¼ initial number of seeded keratinocytes. All PD values were
individually collected (once every 4 days) and were used cumulatively.
Flow cytometry analysis. All flow cytometry analytical runs were performed
on a BD LSRII fitted with a Blue Argon Laser 488 nm, violet diode 405 nm, red
diode 633 nm and a UV laser 325 nm (BD Biosciences), using the BD FACSDiva
Software (BD Biosciences).
For flow cytometry-Hoechst-33342 (Sigma-Aldrich) analysis, cells were
trypsinised and centrifuged at 1000 r.p.m. for 5 min. After washing with
1 PBS and spinning at 1000 r.p.m. for 5 min, cell pellets were resuspended
in Hoechst-33342 10 mg/ml in 1 PBS. After 1-h incubation at 37 1C
in a humidified atmosphere of 10% (v/v) CO2/90% (v/v) air, cells were filtered
through a 70-mm strainer and cellular DNA content was measured by flow
cytometry.
For flow cytometry—propidium iodide (Sigma-Aldrich) analysis, culture medium
was centrifuged together with trypsinised cells to collect all cells, including detached
cells, at 1500 r.p.m. for 5min. After washing with 1 PBS and spinning at
1500 r.p.m. for 5min, cell pellets were resuspended in ice-cold 70% (v/v) ethanol
and incubated for 2 h at 4 1C. Cells were then centrifuged at 6000 r.p.m. for 2 min.
Supernatant was aspirated and each pellet was washed in 1 PBS and
centrifuged at 6000 r.p.m. for 2min. Cell pellets were then resuspended in 100mM
NaCitrate (Sigma-Aldrich) each and centrifuged at 6000 r.p.m. for 2 min. Next,
supernatant was aspirated and each pellet was resuspended in 300–500ml
PI/RNaseA mixture (50 mg/ml propidium iodide, 125mg/ml RNase A, 38mM
NaCitrate, 1 PBS; all supplied by Sigma-Aldrich). Resuspended cells were
incubated for 10–20min in the dark at room temperature and cellular DNA content
measurement by flow cytometry was carried out, where the same number of events
was acquired for each sample (25 000–50 000 events). Samples were analysed
either in duplicates or triplicates.
Cy5 Annexin V staining. For Cy5 Annexin V (BD Biosciences) and DAPI
staining followed by flow cytometry analysis, equal numbers of N/TERT, SINCE
and SINEG2 cells were seeded in 6-cm dishes, and collected either 24 or 48 h
after plating, or were collected after 24 h of mock treatment or UVB treatment for
24 h in order to detect UVB-induced apoptosis. Culture media from each of UVB-
treated culture dishes were also collected to include any detached dead or
apoptotic cells that may be floating in the medium. After centrifugation, cells were
resuspended in 100ml of 1 Annexin V-binding buffer solution (BD Biosciences)
and 5ml Cy5 Annexin V antibody (BD Biosciences) or without antibody (negative
controls). Resuspended cells were then gently vortexed and were incubated for
15min at room temperature in the dark. Next, 400ml of 1 Annexin V-binding
buffer solution (BD Biosciences) was added per sample and samples were kept on
ice. Finally, DAPI (Sigma-Aldrich) was added at a final concentration of 200 ng/ml
per sample, 1–2min before the cells were given for flow cytometry analysis, where
the same number of events was acquired for each sample (20 000–30 000
events). Samples were analysed in duplicates.
Nuclear staining. For Hoechst-33342 staining, cells were seeded at
equal densities, and as soon as they reached 50–60% confluence they were
washed, trypsinised and stained with 10 mg/ml Hoechst-33342 (Sigma-Aldrich) in
suspension for 1 h at 37 1C. Cells were then seeded at equal densities, and
digital bright-field and fluorescent images were captured 24, 48 and 72 h
(B30–60% confluent throughout the experiment) after plating.
For DAPI staining, cells were fixed 72 h after plating (B40–60% confluent) in 4%
(v/v) formaldehyde/formalin (Fisher) solution for 20min at room temperature and
were stained with 200 ng/ml DAPI (Sigma-Aldrich) for 10min at room temperature in
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the dark. Digital bright-field and fluorescent images (B15 images (fields) per cell
line in two replicate wells) were captured using a fluorescence microscope. The
binucleated (tetraploid) cells per field (image) were counted using Adobe Photoshop
CS4 Extended (Adobe Systems Europe, Bergshire, UK). The percentage of
binucleated cells per field was derived by counting the number of cells with two
nuclei over the total number of cells per field. Thus, the percentage of binucleated
cells per field (x) was calculated as follows: x¼ number of binucleate cells 100/
total number of cells. An average ofB300–350 cells were counted for each cell line
in total. Only binulceated cells were counted in this analysis, whereas all
multinucleated cells were included in the total number of cells per field. Cells
undergoing mitosis were also counted as two mononuclear cells.
Reverse-transcription PCR. Total RNA was extracted from cells using
RNeasy Mini Kit (Qiagen, West Sussex, UK) and RNA (1–2mg) was reverse
transcribed into cDNA with the Reverse transcription kit (Promega, Hampshire,
UK) according to manufacturer’s protocols.
Real-time quantitative PCR. Real-time quantitative PCR (qRT-PCR) was
performed as previously described.65 Briefly, qRT-PCR runs were performed in
the LightCycler 480 qPCR system (Roche Diagnostics). Relative quantification of
mRNA transcripts was performed by LightCycler 480 Advanced Relative
Quantification software (Roche Diagnostics) with at least two reference genes for
each analytical run. Samples were analysed in triplicates and significance values
were calculated by Graphpad Instat software (GraphPad Software, San Diego,
CA, USA) by using two-sided P-values or using ANOVA analysis for multiple
sample comparisons. All primer sequences are listed in the Supplementary
Table S1. Using the GeNorm algorithm analysis method,66 and the LightCycler
480 Relative Quantification Software programme (Roche Diagnostics; with built-
in multiple reference genes normalisation algorithm), of the eight reference
genes (GAPDH, RPLPO, YAP1, UBC, HPRT1, POLR2A, ESD and 18S), two
were identified as being most reliable and stable reference genes: polymerase
(RNA) II (DNA directed) polypeptide A (POLR2A) and Yes-associated protein 1
(YAP1) across a large panel of normal and cancer human cells and tissues.65
Semiquantitative PCR. Semiquantitative PCR analysis was performed in
Verity 96-well Thermal Cycler (Applied Biosystems, Foster City, CA, USA) for the
visualisation of GLI2 (whole-gene amplification or a/b-isoform-specific amplifica-
tion) gene mRNA expression. Samples were run on a typical PCR amplification
protocol (95 1C for 10 s, 60 1C for 6 s, 72 1C for 6 s) for 36 cycles for GLI2
full-length and POLR2A, and to 27 and 30 cycles for GLI2 a/b and POLR2A,
respectively. PCR products were visualised by UV light and a gel image was
captured in the Autochemi imaging system (UVP). Primer sequences are listed in
Supplementary Table S1.
Immunoblot analysis. Total cell protein extraction and immunoblot analysis
was performed as previously described.65 For the extraction of total protein from
UVB-irradiated cells, culture media were also collected by centrifugation to include
any dead or apoptotic cells in the medium. Primary antibodies used were: goat
polyclonal anti-14-3-3s (N-14, sc-7681, Santa Cruz, Heidelberg, Germany), mouse
monoclonal anti-Bcl-2 (100, sc-509, Santa Cruz), rabbit polyclonal anti-Caspase-3
(Cell Signaling, Danvers, MA, USA), rabbit polyclonal anti-EGFP (ab-290, Abcam,
Cambridge, UK), rabbit polyclonal anti-GLI2 (H300, Santa Cruz), mouse
monoclonal anti-p21WAF1/CIP1 (Santa Cruz), mouse monoclonal anti-p53 (DO1,
CRUK, Lincoln’s Inn Fields, London, UK) and mouse monoclonal anti-b-actin,
Sigma-Aldrich). Secondary HRP antibodies were as follows: polyclonal rabbit anti-
mouse immunoglobulin/HRP (DakoCytomation, Cambridgeshire, UK), polyclonal
goat anti-rabbit immunoglobulin/HRP (DakoCytomation) and polyclonal rabbit anti-
goat immunoglobulin/HRP (DakoCytomation).
UVB irradiation. Initially, the growth medium of semiconfluent (50–65%) cells
was aspirated. The culture dishes were then inserted in the UV cross-linker (UVP)
and the lids were removed. Cells were irradiated with UVB at different doses
(10–30mJ/cm2) and fresh growth medium was replaced immediately after UVB
exposure. Routine calibration was performed to ensure UVB emission peak at 312 nm,
which is physiologically relevant to skin photobiology. Similar procedure was followed
for the control cells except the UVB-exposure step (non-UVB-treated control cells).
Navitoclax (ABT-263) treatment. Cells were grown in monolayer until
B60% confluence. Next, cells were treated with a range of different doses of
Navitoclax (ABT-263) dissolved in DMSO. Untreated cells were always used as
controls and exposed to equal volume of DMSO as for treated cells. Navitoclax
(ABT-263) was purchased from Selleck Chemicals (Houston, TX, USA).
Multiplex fluorescent in situ hybridisation. Metaphase cells were
collected by standard cytogenetic methods. Twenty four-colour FISH was carried
out as previously described67,68 by following the Vysis M-FISH protocol and using
the SpectraVysion DNA probe (Abbott Molecular, Berkshire, UK). The computer
software SpectroVision (Abbott Molecular) was used to capture and analyse the
images. More than 10 M-FISH karyotypes were analysed for each cell line and
rearrangements detected in two or more metaphases were considered as clonal.
Immunohistochemistry analysis of BCC clinical samples. The
protein expression levels of p21WAF1/CIP1 (p21) were examined in 16 biopsies
comprising normal skin and human BCC subtypes, including nodular (n¼ 9),
superficial (n¼ 4) and infiltrative (n¼ 3). Immunohistochemistry analysis of
p21WAF1/CIP1 was performed using p21WAF1/CIP1 mouse monoclonal antibody
(DCS60, Cell Signaling) at 1 : 125 dilution. Tissue processing and tissue sections
were cut at the Pathology Department of the Institute of Cancer, Barts and the
London School of Medicine and Dentistry, Charterhouse Square, London, UK.
Briefly, 4-mm tissue sections were cut from the BCC paraffin blocks and
transferred on to charged microscope slides. The slides were dried in a 37-1C
oven overnight and then run on Ventana discovery platform (Ventana Molecular
Discovery Systems, Roche Diagnostics) with an automated protocol, including
deparaffinisation, primary and secondary antibody incubation, DAB application,
haematoxylin and bluing reagent counterstaining and finally slides cleaning. After
the run was completed, the slides were placed in soapy tap water and rinsed
under the tap for 1 min and then placed in dH2O. Following dehydration in a series
of solvents, the slides were mounted with coverslips.
Affymetrix 10K SNP analysis. Genomic DNA samples were purified and
processed as described previously.65 Briefly, 350–500 ng of DNA was digested with
XbaI and ligated to the XbaI adaptor before PCR amplification using AmpliTaq Gold
with Buffer II (Applied Biosystems). The PCR amplification profile on an MJ DNA
Engine thermal cycler was: 95/180 (hot start) and 95/20, 59/15,
72/60 (1C/s) for 40 cycles followed by a termination step at 72 1C for 7min. PCR
products were purified using Ultrafree-MC 30 000 NMWL filter columns (catalogue
number UFC-3LTK00; Millipore, Watford, UK) and DNA concentrations determined
using NanoDrop spectrophotometer. Hybridisation and scanning of the arrays were
processed as described previously.65 Evaluation of genomic copy number alterations
was performed using Affymetrix Copy Number Analysis Tool software (CNAT,
version 4) where the threshold for statistical significance was Pr10 6 as
recommended by Affymetrix. The data was cross verified and genome ploidy±S.D.
for Log2 ratio values were obtained using an independent algorithm, Copy Number
Analyzer for GeneChip (version 2; Department of Regeneration Medicine, University
of Tokyo, Tokyo, Japan). Average SNP call rates for all chips were 95–99%.
Statistical analysis. Statistical analysis was performed using either the
Microsoft Excel’s software or the GraphPad’s InStat (V2-04a) and Prism Software
(V5,0; GraphPad Software) for Student’s t-test analysis.
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